Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic : How Do You Make Up For Lost Time?
Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine..
Transfer of select, medically refractory acute respiratory distress syndrome patients to lung transplant centers requires extensive resources. Here, we report 270 consecutive lung transplant patient referrals to our center for medically refractory ARDS from June 2021 to April 2022, following the implementation of clinical care pathways for intake of these patients. Eighty-seven of 270 patients (32.2%) met screening criteria and were evaluated for transfer within a median of 12 days, during which 38 of 87 patients (43.7%) died and 12 of 87 patients (13.8%) transferred elsewhere. Thirty-seven of 87 patients (42.5%) were accepted for transfer of which 16 of 37 patients (43.2%) successfully transferred to our center with a median transfer waiting period of 12 days. Because of resource constraints, 21 of 37 accepted patients (56.8%) could not be transferred of which 9 of 21 patients (42.9%) died while waiting. Nine of 16 transferred patients (56.2%) eventually underwent lung transplantation with over 80% 6-month survival. ARDS patients referred for transplantation have high risk of mortality and, therefore, require well-described pathways for evaluation and transfer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
---|---|
Enthalten in: |
Critical care explorations - 5(2023), 9 vom: 21. Sept., Seite e0965 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cerier, Emily J [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute respiratory distress syndrome |
---|
Anmerkungen: |
Date Revised 13.09.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1097/CCE.0000000000000965 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361907761 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361907761 | ||
003 | DE-627 | ||
005 | 20231226090134.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/CCE.0000000000000965 |2 doi | |
028 | 5 | 2 | |a pubmed24n1206.xml |
035 | |a (DE-627)NLM361907761 | ||
035 | |a (NLM)37693304 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cerier, Emily J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic |b How Do You Make Up For Lost Time? |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 13.09.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. | ||
520 | |a Transfer of select, medically refractory acute respiratory distress syndrome patients to lung transplant centers requires extensive resources. Here, we report 270 consecutive lung transplant patient referrals to our center for medically refractory ARDS from June 2021 to April 2022, following the implementation of clinical care pathways for intake of these patients. Eighty-seven of 270 patients (32.2%) met screening criteria and were evaluated for transfer within a median of 12 days, during which 38 of 87 patients (43.7%) died and 12 of 87 patients (13.8%) transferred elsewhere. Thirty-seven of 87 patients (42.5%) were accepted for transfer of which 16 of 37 patients (43.2%) successfully transferred to our center with a median transfer waiting period of 12 days. Because of resource constraints, 21 of 37 accepted patients (56.8%) could not be transferred of which 9 of 21 patients (42.9%) died while waiting. Nine of 16 transferred patients (56.2%) eventually underwent lung transplantation with over 80% 6-month survival. ARDS patients referred for transplantation have high risk of mortality and, therefore, require well-described pathways for evaluation and transfer | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a acute respiratory distress syndrome | |
650 | 4 | |a hospital transfer | |
650 | 4 | |a intensive care unit | |
650 | 4 | |a lung transplantation | |
650 | 4 | |a quality improvement | |
700 | 1 | |a Toyoda, Takahide |e verfasserin |4 aut | |
700 | 1 | |a McNulty, Colleen |e verfasserin |4 aut | |
700 | 1 | |a O'Boye, Anne |e verfasserin |4 aut | |
700 | 1 | |a Kurihara, Chitaru |e verfasserin |4 aut | |
700 | 1 | |a Bharat, Ankit |e verfasserin |4 aut | |
700 | 1 | |a Nadig, Nandita R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Critical care explorations |d 2019 |g 5(2023), 9 vom: 21. Sept., Seite e0965 |w (DE-627)NLM300504969 |x 2639-8028 |7 nnns |
773 | 1 | 8 | |g volume:5 |g year:2023 |g number:9 |g day:21 |g month:09 |g pages:e0965 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/CCE.0000000000000965 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 5 |j 2023 |e 9 |b 21 |c 09 |h e0965 |